These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30834707)

  • 1. Correlation Between Conditional Approval and Customized Bone Implant Devices.
    Guo XL; Liu B; Lu Z
    Orthop Surg; 2019 Feb; 11(1):10-14. PubMed ID: 30834707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Market approval processes for new types of spinal devices: challenges and recommendations for improvement.
    Bisschop A; van Tulder MW
    Eur Spine J; 2016 Sep; 25(9):2993-3003. PubMed ID: 27235154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthopedic devices; effective data of requirement for premarket approval for hip joint metal/polymer or ceramic/polymer semiconstrained resurfacing cemented prosthesis. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Oct; 69(191):59132-4. PubMed ID: 15460583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal devices in the United States-investigational device exemption trials and premarket approval of class III devices.
    Golish SR; Reed ML
    Spine J; 2017 Jan; 17(1):150-157. PubMed ID: 27737804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
    Samuel AM; Rathi VK; Grauer JN; Ross JS
    Clin Orthop Relat Res; 2016 Apr; 474(4):1053-68. PubMed ID: 26584802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical trials investigating the therapeutic benefit of medical devices in orthopaedics and trauma surgery: practice examples plus commentary].
    Kirschner S
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(5):342-6; discussion 346. PubMed ID: 22818155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Discussion about Supervision Model of Customized Medical Device].
    Sun J; Wu J; Qian H; Liu B; Zhang S
    Zhongguo Yi Liao Qi Xie Za Zhi; 2017 Nov; 41(6):432-435. PubMed ID: 29862704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory approval of new medical devices: cross sectional study.
    Marcus HJ; Payne CJ; Hughes-Hallett A; Marcus AP; Yang GZ; Darzi A; Nandi D
    BMJ; 2016 May; 353():i2587. PubMed ID: 27207165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-Computer Interface devices: risks and Canadian regulations.
    Alpert S
    Account Res; 2008; 15(2):63-86. PubMed ID: 18593098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthopaedic Device Approval Through the Premarket Approval Process: A Financial Feasibility Analysis for a Single Center.
    Yang BW; Iorio ML; Day CS
    J Bone Joint Surg Am; 2017 Mar; 99(6):e26. PubMed ID: 28291189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion of comparative effectiveness data in high-risk cardiovascular device studies at the time of premarket approval.
    Chen CE; Dhruva SS; Redberg RF
    JAMA; 2012 Nov; 308(17):1740-2. PubMed ID: 23117769
    [No Abstract]   [Full Text] [Related]  

  • 12. Review and approval of medical devices in China: Changes and reform.
    Liu W; Shi X; Lu Z; Wang L; Zhang K; Zhang X
    J Biomed Mater Res B Appl Biomater; 2018 Aug; 106(6):2093-2100. PubMed ID: 29080388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and effectiveness considerations for clinical studies of visual prosthetic devices.
    Cohen ED
    J Neural Eng; 2007 Mar; 4(1):S124-9. PubMed ID: 17325410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current situation and development of medical device testing institutes in China.
    Yang X; Mu R; Fan Y; Wang C; Li D
    Expert Rev Med Devices; 2017 Apr; 14(4):263-269. PubMed ID: 28388243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of US Food and Drug Administration Premarket Approval Statements for High-Risk Medical Devices With Pediatric Age Indications.
    Lee SJ; Cho L; Klang E; Wall J; Rensi S; Glicksberg BS
    JAMA Netw Open; 2021 Jun; 4(6):e2112562. PubMed ID: 34156454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of the 2017 US Food and Drug Administration Circulatory System Devices Panel meeting on the Sentinel Cerebral Protection System.
    Rogers T; Alraies MC; Torguson R; Waksman R
    Am Heart J; 2017 Oct; 192():113-119. PubMed ID: 28938957
    [No Abstract]   [Full Text] [Related]  

  • 17. [State and perspectives of development of the prosthesis-orthopedic aid in the RSFSR].
    Kondrashin NI; Avdoshin VV
    Ortop Travmatol Protez; 1973 Oct; 34(10):1-7. PubMed ID: 4792980
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical devices face tougher premarket testing under new EU laws.
    Cohen D
    BMJ; 2017 Apr; 357():j1870. PubMed ID: 28408538
    [No Abstract]   [Full Text] [Related]  

  • 19. Evolution of China regulatory guidance on the clinical evaluation of medical devices and its implication on pre-market and post-approval clinical evaluation strategies.
    Su G; Deng D
    Expert Rev Med Devices; 2023 Mar; 20(3):167-178. PubMed ID: 36860133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceuticals and medical devices: medical devices. Year end issue brief.
    Tiffany S
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-19. PubMed ID: 18345548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.